Insider Trading Tracker: Live US Stock Disclosures & Insider Buying made on Jan 23, 2025

Advanced/Help

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Showing you 400 results sorted by most recent dates. Subscribe to see a larger data set

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Roivant Sciences Ltd	Vivek Ramaswamy	Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	13,357,857	13,357,857	-		0	Common Shares
Roivant Sciences Ltd	Vivek Ramaswamy	Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	13,357,857	40,073,570	-		0	Common Shares
Alphabet (Class A) Results Board Meeting	Sundar Pichai	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	1,343,392	3,387,756 (0%)	0%		0	Class C Capital Stock
Cogent Biosciences Inc	Andrews R. Robbins	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	915,000	915,000	-		-	Stock Option (Right to Buy)
Alphabet (Class A) Results Board Meeting	Sundar Pichai	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 200.03 per share.	23 Jan 2025	674,712	2,713,044 (0%)	0%	200.0	134,962,641	Class C Capital Stock
Arcus Biosciences Inc	Terry Rosen	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	650,000	650,000	-		-	Stock Option (right to buy)
Micron Tech	Sanjay Mehrotra	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	23 Jan 2025	500,000	500,000 (0%)	0%		0	Common Stock
Micron Tech	Sanjay Mehrotra	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	23 Jan 2025	500,000	586,702 (0%)	0%		0	Common Stock
Scynexis Inc	David Angulo	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	394,391	394,391	-		-	Employee Stock Option (Right to Buy)
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	390,000	390,000 (0%)	0%		0	Class A Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	390,000	0	-		-	Class B Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	390,000	390,000	-		-	Class B Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	390,000	598,852	-		-	Employee Stock Option (Right to Buy)
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Sale of securities on an exchange or to another person at price $ 86.99 per share.	23 Jan 2025	325,520	64,480 (0%)	0%	87.0	28,317,441	Class A Common Stock
Pliant Therapeutics Inc	Bernard Coulie	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	325,000	325,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	John L. Green	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	270,000	270,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Jessica Sachs	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	270,000	270,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	John Edward Robinson	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	270,000	270,000	-		-	Stock Option (Right to Buy)
Scynexis Inc	David Angulo	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	262,927	770,798 (0%)	0%		0	Common Stock
Adamas Trust Inc	Jason T. Serrano	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	254,211	370,453	-		-	Restricted Stock Units
Cogent Biosciences Inc	Cole Pinnow	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	240,000	240,000	-		-	Stock Option (Right to Buy)
Cogent Biosciences Inc	Evan Kearns	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	230,000	230,000	-		-	Stock Option (Right to Buy)
Arcus Biosciences Inc	Juan Carlos Jaen	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	200,000	200,000	-		-	Stock Option (right to buy)
Arcus Biosciences Inc	Jennifer Ann Jarrett	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	200,000	200,000	-		-	Stock Option (right to buy)
Micron Tech	Sanjay Mehrotra	Director, President and CEO	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	182,401	0 (0%)	0%		0	Common Stock
i3 Verticals Inc (Class A)	Gregory Daily	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2025	172,513	4,506,168	-		0	Class B common stock, par value $0.0001 per share
X4 Pharma Inc	Paula S. Ragan	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	169,940	1,163,859 (7%)	1%		0	Common Stock
Arcus Biosciences Inc	Terry Rosen	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	165,000	2,534,360 (5%)	0%		0	Common Stock
Comtech Telecom Corp	Kenneth H. Traub	Director, Chairman, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	163,935	163,935	-		-	Restricted Stock Units
Pliant Therapeutics Inc	Bernard Coulie	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	162,500	593,017	-		0	Common Stock
Micron Tech	Sanjay Mehrotra	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	23 Jan 2025	156,293	1,086,702 (0%)	0%		0	Common Stock
Micron Tech	Sanjay Mehrotra	Director, President and CEO	Other type of transaction at price $ 0.00 per share.	23 Jan 2025	156,293	182,401 (0%)	0%		0	Common Stock
Asana Inc (Class A)	Justin Rosenstein	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 20.01 per share.	23 Jan 2025	150,000	2,047,309	-	20.0	3,001,500	Class A Common Stock
Arcus Biosciences Inc	Robert C. Goeltz	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	150,000	150,000	-		-	Stock Option (right to buy)
Arcus Biosciences Inc	Carolyn C. Tang	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	150,000	150,000	-		-	Stock Option (right to buy)
Adamas Trust Inc	Nicholas Mah	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	146,842	235,500	-		-	Restricted Stock Units
Globus Medical Inc (Class A)	Daniel T. Scavilla	Director, President, CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	140,000	140,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Scynexis Inc	Scott Sukenick	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	138,767	138,767	-		-	Employee Stock Option (Right to Buy)
Scynexis Inc	Ivor Macleod	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	138,767	138,767	-		-	Employee Stock Option (Right to Buy)
GRI Bio Inc	W. Marc Hertz	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	129,730	129,730	-		-	Stock Option (Right to Buy)
Keycorp Results Board Meeting	Mohit Ramani	Chief Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	117,344	117,344	-		-	Restricted Stock Units
ThredUp Inc (Class A)	Patricia Nakache	Director		23 Jan 2025	117,300	4,593,733	-		-	Class B Common Stock
ThredUp Inc (Class A)	Patricia Nakache	Director	Sale of securities on an exchange or to another person at price $ 2.23 per share.	23 Jan 2025	117,300	0	-	2.2	261,579	Class A Common Stock
ThredUp Inc (Class A)	Patricia Nakache	Director		23 Jan 2025	117,300	117,300	-		0	Class A Common Stock
Pliant Therapeutics Inc	Keith Cummings	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	113,300	113,300	-		-	Stock Option (Right to Buy)
Progress Software Corp	Yogesh K. Gupta	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	113,137	113,137	-		-	Employee Stock Options (Right to buy)
ThredUp Inc (Class A)	Patricia Nakache	Director		23 Jan 2025	106,272	106,272	-		0	Class A Common Stock
ThredUp Inc (Class A)	Patricia Nakache	Director		23 Jan 2025	106,272	4,711,033	-		-	Class B Common Stock
ThredUp Inc (Class A)	Patricia Nakache	Director	Sale of securities on an exchange or to another person at price $ 2.10 per share.	23 Jan 2025	106,272	0	-	2.1	223,171	Class A Common Stock
Symbotic Inc (Class A)	Carol J. Hibbard	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	100,554	100,554	-		-	Restricted Stock Units
Microvast Holdings Inc	Wenjuan Mattis	Chief Technology Officer (CTO)	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	100,000	802,538	-		-	Common Stock
Microvast Holdings Inc	Isida Tushe	Director, Pres., Gen. Couns. & Corp. Sec	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	100,000	100,000	-		-	Common Stock
A10 Networks Inc	Dhrupad Trivedi	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	99,410	627,213 (0%)	0%		0	Common Stock
A10 Networks Inc	Dhrupad Trivedi	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	99,410	0	-		-	Performance-based Restricted Stock Units
i3 Verticals Inc (Class A)	Gregory Daily	Director, Chief Executive Officer, Ten Percent Owner	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2025	93,774	2,449,437	-		0	Class B common stock, par value $0.0001 per share
Scynexis Inc	Scott Sukenick	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	92,511	436,706 (0%)	0%		0	Common Stock
Scynexis Inc	Ivor Macleod	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	92,511	260,696 (0%)	0%		0	Common Stock
Pliant Therapeutics Inc	Eric Lefebvre	Chief Medical Officer		23 Jan 2025	91,300	91,300	-		-	Stock Option (Right to Buy)
Galectin Therapeutics Inc	Joel Lewis	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	91,000	91,000	-		-	Stock Option (right to buy)
P&G Dividend	Marc S. Pritchard	Chief Brand Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 85.13 per share.	23 Jan 2025	90,450	263,264 (0%)	0%	85.1	7,700,009	Common Stock
P&G Dividend	Marc S. Pritchard	Chief Brand Officer	Sale of securities on an exchange or to another person at price $ 163.84 per share.	23 Jan 2025	90,450	172,814 (0%)	0%	163.8	14,819,030	Common Stock
P&G Dividend	Marc S. Pritchard	Chief Brand Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	90,450	0	-		-	Stock Option (Right to Buy)
Energy Recovery Inc	David W. Moon	Director, President and CEO		23 Jan 2025	88,980	176,081 (0%)	0%		0	Common Stock
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	86,389	0	-		-	Performance Stock Units
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	86,389	525,457	-		0	Class A common stock
Galectin Therapeutics Inc	Joel Lewis	Director, President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	84,000	84,000	-		-	Restricted Stock Unit
Novavax Inc	John C. Jacobs	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	83,196	130,722 (0%)	0%		0	Common Stock
Novavax Inc	John C. Jacobs	Director, President and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	83,196	83,197	-		-	Restricted Stock Units
Progress Software Corp	Yogesh K. Gupta	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	83,149	83,149	-		-	Restricted Stock Units
Pliant Therapeutics Inc	Hans P. Hull	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	80,300	80,300	-		-	Stock Option (Right to Buy)
X4 Pharma Inc	Paula S. Ragan	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 0.45 per share.	23 Jan 2025	76,473	1,087,386 (6%)	0%	0.5	34,719	Common Stock
Symbotic Inc (Class A)	William M. Boyd	Chief Strategy Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	75,416	75,416	-		-	Restricted Stock Units
Globus Medical Inc (Class A)	David C. Paul	Director, Executive Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	75,000	75,000	-		-	Stock Option (Right to Buy Class A Common Stock)
X4 Pharma Inc	Adam S. Mostafa	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	74,773	74,773 (0%)	0%		0	Common Stock
X4 Pharma Inc	Adam S. Mostafa	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 0.45 per share.	23 Jan 2025	74,773	0 (0%)	0%	0.5	33,947	Common Stock
X4 Pharma Inc	Mark Baldry	Chief Commercial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	74,773	123,282 (0%)	0%		0	Common Stock
Adamas Trust Inc	Kristine R. Nario-Eng	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	72,368	106,751	-		-	Restricted Stock Units
Pliant Therapeutics Inc	Mike Ouimette	General Counsel & Corp. Secy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	70,000	70,000	-		-	Stock Option (Right to Buy)
Innovative Soln And Support Inc	Christopher Harborne	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 11.21 per share.	23 Jan 2025	69,599	2,431,570 (14%)	0%	11.2	780,421	Common Stock, par value $0.001 per share
Cadrenal Therapeutics Inc	Quang X. Pham	Director, CEO and Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	65,000	65,000	-		-	Stock Options
Galectin Therapeutics Inc	Jack W. Callicutt	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	65,000	65,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	65,000	65,000	-		-	Stock Option (right to buy)
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	65,000	0	-		-	Class B Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	65,000	65,000	-		-	Class B Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	65,000	533,852	-		-	Employee Stock Option (Right to Buy)
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Sale of securities on an exchange or to another person at price $ 88.50 per share.	23 Jan 2025	65,000	0 (0%)	0%	88.5	5,752,500	Class A Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	65,000	65,000 (0%)	0%		0	Class A Common Stock
Cadrenal Therapeutics Inc	Quang X. Pham	Director, CEO and Chairman, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	65,000	65,000	-		-	Stock Options
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 153.41 per share.	23 Jan 2025	64,437	1,347,034	-	153.4	9,885,280	Class A Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Sale of securities on an exchange or to another person at price $ 87.57 per share.	23 Jan 2025	63,508	972 (0%)	0%	87.6	5,561,218	Class A Common Stock
AT&T Results Board Meeting	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	62,672	62,672 (0%)	0%		0	Common Stock
AT&T Results Board Meeting	David R. McAtee	Sr. Exec. VP and Gen. Counsel	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	62,672	239,857 (0%)	0%		0	Common Stock
X4 Pharma Inc	Mary DiBiase	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	61,178	513,238 (3%)	0%		0	Common Stock
Galectin Therapeutics Inc	Benjamin S. Carson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Gilbert S. Omenn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Gilbert S. Omenn	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Jack W. Callicutt	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Restricted Stock Unit
Galectin Therapeutics Inc	Marc Rubin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Kevin D. Freeman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Kary Eldred	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Richard E. Uihlein	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Elissa J. Schwartz	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Richard A. Zordani	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Galectin Therapeutics Inc	Khurram Jamil	Chief Medical Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Restricted Stock Unit
Galectin Therapeutics Inc	Harold H. Shlevin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (right to buy)
Globus Medical Inc (Class A)	Keith W. Pfeil	COO, CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	60,000	60,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Xometry Inc (Class A)	Sanjeev Singh Sahni	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	58,200	58,200	-		0	Class A Common Stock
Pliant Therapeutics Inc	Keith Cummings	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	56,650	319,258	-		0	Common Stock
Tenet Healthcare Corp Results Board Meeting	Saumya Sutaria	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	52,065	52,065	-		-	2025 January Restricted Stock Units
GRI Bio Inc	David Szekeres	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	51,937	51,937	-		-	Stock Option (Right to Buy)
Lithium Americas Corp	Jonathan D. Evans	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	51,838	564,210	-		0	Common Shares
Lithium Americas Corp	Jonathan D. Evans	Director, President & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	51,838	103,677	-		-	Restricted Stock Units
Pliant Therapeutics Inc	Lily Cheung	Chief Human Resource Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	51,750	51,750	-		-	Stock Option (Right to Buy)
Cadrenal Therapeutics Inc	Matthew K. Szot	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	50,000	50,000	-		-	Stock Options
Loop Ind Inc Board Meeting	Jay Stubina	Director	Purchase of securities on an exchange or from another person at price $ 1.20 per share.	23 Jan 2025	50,000	135,000 (0%)	0%	1.2	60,000	Common Stock
Arcus Biosciences Inc	Juan Carlos Jaen	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	50,000	367,220 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Jennifer Ann Jarrett	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	50,000	213,369 (0%)	0%		0	Common Stock
Progress Software Corp	Yogesh K. Gupta	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	49,890	49,890	-		-	Restricted Stock Units
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 152.57 per share.	23 Jan 2025	49,027	1,201,789	-	152.6	7,480,049	Class A Common Stock
Phreesia Inc	Chaim Indig	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	48,910	1,286,448 (3%)	0%		0	Common Stock
NiSource	Lloyd M. Yates	Director, Director and President & CEO	Grant, award, or other acquisition of securities at price $ 37.60 per share.	23 Jan 2025	47,872	242,815 (0%)	0%	37.6	1,799,987	Common Stock
Microvast Holdings Inc	Lap Tat Arthur Wong	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	47,738	177,330	-		-	Common Stock
Microvast Holdings Inc	Wei Ying	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	47,738	296,966	-		-	Common Stock
Microvast Holdings Inc	Yixin Pan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	47,738	140,692	-		-	Common Stock
Jabil Buyback	John C. Plant	Director	Sale of securities on an exchange or to another person at price $ 172.50 per share.	23 Jan 2025	46,200	5,900 (0%)	0%	172.5	7,969,500	Common Stock
Wave Life Sciences Ltd	Chandra Vargeese	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.48 per share.	23 Jan 2025	46,000	233,933 (0%)	0%	2.5	114,080	Ordinary Shares
Wave Life Sciences Ltd	Chandra Vargeese	See Remarks	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	46,000	16,422	-		-	Share Option (right to buy)
Pliant Therapeutics Inc	Eric Lefebvre	Chief Medical Officer		23 Jan 2025	45,650	240,224	-		0	Common Stock
Symbotic Inc (Class A)	Michael Dunn	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	45,250	45,250	-		-	Restricted Stock Units
Cardlytics Inc	Amit Gupta	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	43,750	230,654 (0%)	0%		-	Common Stock
Cardlytics Inc	Amit Gupta	Director, Chief Executive Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	43,750	0	-		-	Restricted Stock Unit
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 149.77 per share.	23 Jan 2025	43,455	1,099,639	-	149.8	6,508,255	Class A Common Stock
GRI Bio Inc	Leanne M. Kelly	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	43,319	43,319	-		-	Stock Option (Right to Buy)
GRI Bio Inc	Vipin Kumar Chaturvedi	Chief Scientific Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	43,319	43,319	-		-	Stock Option (Right to Buy)
Progress Software Corp	Anthony Folger	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	41,484	41,484	-		-	Employee Stock Options (Right to buy)
Symbotic Inc (Class A)	Maria G. Freve	See Remarks	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	41,478	41,478	-		-	Restricted Stock Units
Ramaco Resources Inc (Class A)	Christopher L. Blanchard	EVP Mine Planning & Developmen	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	40,431	0	-		-	Performance Stock Units
Ramaco Resources Inc (Class A)	Christopher L. Blanchard	EVP Mine Planning & Developmen	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	40,431	416,751	-		0	Class A common stock
Ramaco Resources Inc (Class A)	Jeremy R. Sussman	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	40,431	345,315	-		0	Class A common stock
Ramaco Resources Inc (Class A)	Jeremy R. Sussman	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	40,431	0	-		-	Performance Stock Units
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 153.25 per share.	23 Jan 2025	40,185	1,241,974	-	153.2	6,158,351	Class A Common Stock
Pliant Therapeutics Inc	Hans P. Hull	Chief Business Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	40,150	251,708	-		0	Common Stock
Globus Medical Inc (Class A)	Kelly G. Huller	SVP, GC, Corporate Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	40,000	40,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	39,996	217,672	-		-	Class B Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	39,996	39,996 (0%)	0%		0	Class A Common Stock
Novavax Inc	John C. Jacobs	Director, President and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.55 per share.	23 Jan 2025	38,873	91,849 (0%)	0%	9.5	371,237	Common Stock
CarGurus Inc (Class A)	Langley Steinert	Director, Executive Chair, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 39.34 per share.	23 Jan 2025	37,634	657,722 (0%)	0%	39.3	1,480,687	Class A Common Stock
Arcus Biosciences Inc	Robert C. Goeltz	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	37,000	97,138 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	Carolyn C. Tang	General Counsel	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	37,000	137,623 (0%)	0%		0	Common Stock
Xometry Inc (Class A)	Sanjeev Singh Sahni	President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	35,566	93,766	-		0	Class A Common Stock
Pliant Therapeutics Inc	Mike Ouimette	General Counsel & Corp. Secy	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	35,000	105,544	-		0	Common Stock
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share.	23 Jan 2025	34,558	490,899	-	9.7	335,558	Class A common stock
Ramaco Resources Inc (Class A)	Jason Todd Fannin	CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	34,556	156,609	-		0	Class A common stock
Ramaco Resources Inc (Class A)	Jason Todd Fannin	CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	34,556	0	-		-	Performance Stock Units
Energy Recovery Inc	Rodney Clemente	SVP, Water	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	34,223	140,590 (0%)	0%		0	Common Stock
Energy Recovery Inc	Michael Mancini S.	Chief Financial Officer		23 Jan 2025	34,223	34,223 (0%)	0%		0	Common Stock
A10 Networks Inc	Dhrupad Trivedi	Director, Chief Executive Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.46 per share.	23 Jan 2025	33,953	593,260 (0%)	0%	19.5	660,725	Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Sale of securities on an exchange or to another person at price $ 86.99 per share.	23 Jan 2025	33,383	6,613 (0%)	0%	87.0	2,904,031	Class A Common Stock
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 152.80 per share.	23 Jan 2025	32,637	1,132,276	-	152.8	4,986,934	Class A Common Stock
Galectin Therapeutics Inc	Richard E. Uihlein	Director, Ten Percent Owner	Grant, award, or other acquisition of securities at price $ 1.23 per share.	23 Jan 2025	32,520	10,301,271 (18%)	0%	1.2	40,000	Common Stock
Fastly Inc (Class A)	Artur Bergman	Director, Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 10.31 per share.	23 Jan 2025	31,551	3,394,136 (4%)	0%	10.3	325,291	Class A Common Stock
Regions Financial	Brian R. Willman	SEVP		23 Jan 2025	31,347	31,347	-		-	Phantom Stock Units
Microvast Holdings Inc	Yang Wu	Director, Chairman & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	31,083	83,568,036	-		-	Common Stock
374Water Inc Board Meeting	Yaacov Nagar	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.60 per share.	23 Jan 2025	31,025	36,774,695	-	0.6	18,522	Common Stock
Progress Software Corp	Anthony Folger	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	30,488	30,488	-		-	Restricted Stock Units
GRI Bio Inc	Roelof Rongen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	30,297	30,297	-		-	Stock Option (Right to Buy)
GRI Bio Inc	Camilla V. Simpson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	30,297	30,297	-		-	Stock Option (Right to Buy)
GRI Bio Inc	David Baker	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	30,297	30,297	-		-	Stock Option (Right to Buy)
Lightbridge Corp	Andrey Mushakov	EVP, Nuclear Operations	Sale of securities on an exchange or to another person at price $ 9.68 per share.	23 Jan 2025	30,070	189,893 (5%)	0%	9.7	290,996	Common Stock
X4 Pharma Inc	Mark Baldry	Chief Commercial Officer	Sale of securities on an exchange or to another person at price $ 0.45 per share.	23 Jan 2025	29,159	94,123 (0%)	0%	0.5	13,241	Common Stock
Walmart	C. Douglas McMillon	Director, President and CEO	Sale of securities on an exchange or to another person at price $ 92.62 per share.	23 Jan 2025	29,124	3,766,491 (0%)	0%	92.6	2,697,456	Common Stock
Regions Financial	Brian R. Willman	SEVP		23 Jan 2025	27,943	27,943 (0%)	0%	23.8	665,520	Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 2.43 per share.	23 Jan 2025	27,098	55,016	-	2.4	65,848	Class A Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 30.08 per share.	23 Jan 2025	27,098	27,918	-	30.1	815,029	Class A Common Stock
Hims & Hers Health Inc (Class A)	Andrew Dudum	Director, Chief Executive Officer, Ten Percent Owner	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	27,098	1,506,401	-		-	Stock Option (right to buy)
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	26,826	26,827	-		-	Restricted Share Units
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	26,826	100,894	-		0	Common Shares
Wintrust Fin Corp	Edward J. Wehmer	Director, FOUNDER AND SENIOR ADVISOR	Grant, award, or other acquisition of securities at price $ 133.62 per share.	23 Jan 2025	26,624	196,425 (0%)	0%	133.6	3,557,499	Common Stock
Manhattan Associates Inc Results Board Meeting	Eddie Capel	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	26,473	213,570 (0%)	0%		0	Common Stock
Pliant Therapeutics Inc	Lily Cheung	Chief Human Resource Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,875	50,425	-		0	Common Stock
X4 Pharma Inc	Christophe Arbet-Engels	Chief Medical Officer		23 Jan 2025	25,831	25,831 (0%)	0%		0	Common Stock
J.B. Hunt Transport	Shelley Simpson	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,074	25,074	-		-	Resticted Stock
Cadrenal Therapeutics Inc	Jeffrey Cole	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,000	25,000	-		-	Stock Options
Smith Micro Software Inc	Gregory J. Szabo	Director		23 Jan 2025	25,000	53,000 (0%)	0%		0	Common Stock
Smith Micro Software Inc	Thomas G. Campbell	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,000	39,213 (0%)	0%		0	Common Stock
Smith Micro Software Inc	Steven L. Elfman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,000	48,594 (0%)	0%		0	Common Stock
Smith Micro Software Inc	Samuel Gulko	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,000	49,782 (0%)	0%		0	Common Stock
Smith Micro Software Inc	Andrew Arno	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,000	67,514 (0%)	0%		0	Common Stock
Smith Micro Software Inc	Asha Keddy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	25,000	34,136 (0%)	0%		0	Common Stock
Smith Micro Software Inc	Chetan Sharma	Director		23 Jan 2025	25,000	25,000	-		-	Stock Option (right to buy)
Energy Recovery Inc	William Yeung W.	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	23,956	109,247 (0%)	0%		0	Common Stock
Progress Software Corp	John Ainsworth	EVP/GM App & Data Platform	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	23,256	23,256	-		-	Employee Stock Options (Right to buy)
Progress Software Corp	Loren Jarrett	EVP/GM Digital Experience	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	23,256	23,256	-		-	Employee Stock Options (Right to buy)
Progress Software Corp	Sundar Subramanian	EVP/GM Infrastructure Mgmt	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	23,256	23,256	-		-	Employee Stock Options (Right to buy)
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 152.68 per share.	23 Jan 2025	22,975	1,282,597	-	152.7	3,507,823	Class A Common Stock
Meta Cloud Deal	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner		23 Jan 2025	22,946	193,387,416	-		-	Class B Common Stock
Meta Cloud Deal	Mark Zuckerberg	Director, COB and CEO, Ten Percent Owner		23 Jan 2025	22,946	22,946 (0%)	0%		0	Class A Common Stock
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.76 per share.	23 Jan 2025	22,468	53,770 (0%)	0%	17.8	399,032	Common Shares
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Sale of securities on an exchange or to another person at price $ 40.20 per share.	23 Jan 2025	22,468	31,302 (0%)	0%	40.2	903,214	Common Shares
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	22,468	16,315	-		-	Stock Option (Right to Buy)
X4 Pharma Inc	Mary DiBiase	Chief Operating Officer	Sale of securities on an exchange or to another person at price $ 0.45 per share.	23 Jan 2025	22,258	490,980 (3%)	0%	0.5	10,094	Common Stock
KB Home	Jeffrey T. Mezger	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	22,150	1,636,930 (1%)	0%		0	Common Stock
Westamerica Bancorp	John A. Thorson	SVP/Treasurer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	21,900	21,900	-		-	Non-qualified Stock Option (Right to Buy)
Freshworks Inc (Class A)	Johanna Flower	Director		23 Jan 2025	21,400	62,891	-		0	Class A Common Stock
Freshworks Inc (Class A)	Johanna Flower	Director	Sale of securities on an exchange or to another person at price $ 18.00 per share.	23 Jan 2025	21,400	41,491	-	18	385,200	Class A Common Stock
Freshworks Inc (Class A)	Johanna Flower	Director		23 Jan 2025	21,400	152,900	-		-	Class B Common Stock
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 153.39 per share.	23 Jan 2025	20,486	1,152,762	-	153.4	3,142,348	Class A Common Stock
Cadrenal Therapeutics Inc	John Raymond Murphy	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	20,000	20,000	-		-	Stock Options
Cadrenal Therapeutics Inc	Glynn Wilson	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	20,000	20,000	-		-	Stock Options
Cadrenal Therapeutics Inc	Steven Zelenkofske	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	20,000	20,000	-		-	Stock Options
Cadrenal Therapeutics Inc	Robert Lisicki	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	20,000	20,000	-		-	Stock Options
DoorDash	Prabir Adarkar	PRESIDENT AND COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.16 per share.	23 Jan 2025	20,000	945,222	-	7.2	143,200	Class A Common Stock
DoorDash	Prabir Adarkar	PRESIDENT AND COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	20,000	438,550	-		-	Stock Option (right to buy)
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	19,998	109,378	-		-	Class B Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	19,998	19,998 (0%)	0%		0	Class A Common Stock
Burke & Herbert Fin Services Corp Results	David P. Boyle	Director, Chair & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	19,602	51,431	-		0	Common Stock
Phreesia Inc	Evan Roberts	Chief Operating Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	19,564	775,023 (2%)	0%		0	Common Stock
Phreesia Inc	David Linetsky	SVP, Life Sciences	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	19,564	242,956 (0%)	0%		0	Common Stock
Westamerica Bancorp	Brian J. Donohoe	SVP/Chief Information Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	19,100	19,100	-		-	Non-qualified Stock Option (Right to Buy)
J.B. Hunt Transport	John N. Roberts	Director, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	18,925	18,925	-		-	Restricted Stock
Ramaco Resources Inc (Class A)	Christopher L. Blanchard	EVP Mine Planning & Developmen	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share.	23 Jan 2025	18,456	398,295	-	9.7	179,208	Class A common stock
Progress Software Corp	Anthony Folger	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	18,293	18,293	-		-	Restricted Stock Units
Wintrust Fin Corp	Timothy S. Crane	Director, PRESIDENT & CEO	Grant, award, or other acquisition of securities at price $ 133.62 per share.	23 Jan 2025	18,113	79,972 (0%)	0%	133.6	2,420,259	Common Stock
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,884	91,952	-		0	Common Shares
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,884	35,769	-		-	Restricted Share Units
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,884	91,952	-		0	Common Shares
Lithium Americas Corp	Richard Gerspacher	EVP, Capital Projects	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,884	35,769	-		-	Restricted Share Units
Netflix Estimates Miss	Ted Sarandos	Director, Co-CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	17,330	17,330	-		-	Restricted Stock Units
Netflix Estimates Miss	Gregory K. Peters	Director, Co-CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	17,330	17,330	-		-	Restricted Stock Units
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,278	0	-		-	Performance Stock Units
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,278	114,479	-		0	Class B common stock
Lithium Americas Corp	April Hashimoto	SrVP, Finance & Administration	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,107	34,213	-		-	Restricted Stock Units
Lithium Americas Corp	April Hashimoto	SrVP, Finance & Administration	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	17,107	34,331	-		0	Common Shares
Arcus Biosciences Inc	Alexander Azoy	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	17,100	30,194 (0%)	0%		0	Common Stock
Progress Software Corp	John Ainsworth	EVP/GM App & Data Platform	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	17,092	17,092	-		-	Restricted Stock Units
Progress Software Corp	Loren Jarrett	EVP/GM Digital Experience	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	17,092	17,092	-		-	Restricted Stock Units
Progress Software Corp	Sundar Subramanian	EVP/GM Infrastructure Mgmt	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	17,092	17,092	-		-	Restricted Stock Units
Manhattan Associates Inc Results Board Meeting	Eddie Capel	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	16,844	230,414 (0%)	0%		0	Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Sale of securities on an exchange or to another person at price $ 86.99 per share.	23 Jan 2025	16,717	3,281 (0%)	0%	87.0	1,454,244	Class A Common Stock
J.B. Hunt Transport	Shelley Simpson	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	16,716	16,716	-		-	Resticted Stock
Enphase Energy Results Board Meeting	Badri Kothandaraman	Director, President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	16,500	106,976 (0%)	0%		0	Common Stock
Westamerica Bancorp	Anela Jonas M.	SVP/CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	16,500	16,500	-		-	Non-qualified Stock Option (Right to Buy)
Progress Software Corp	YuFan Stephanie Wang	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	16,342	16,342	-		-	Employee Stock Options (Right to buy)
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	16,315	0	-		-	Stock Option (Right to Buy)
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.76 per share.	23 Jan 2025	16,217	47,519 (0%)	0%	17.8	288,014	Common Shares
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Sale of securities on an exchange or to another person at price $ 40.08 per share.	23 Jan 2025	16,217	31,302 (0%)	0%	40.1	649,977	Common Shares
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	16,217	38,783	-		-	Stock Option (Right to Buy)
Travere Therapeutics Inc	Roy D. Baynes	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	16,000	0	-		-	Stock option (right to buy)
Travere Therapeutics Inc	Roy D. Baynes	Director	Sale of securities on an exchange or to another person at price $ 20.00 per share.	23 Jan 2025	16,000	31,000 (0%)	0%	20	320,000	Common Stock
Travere Therapeutics Inc	Roy D. Baynes	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.50 per share.	23 Jan 2025	16,000	47,000 (0%)	0%	17.5	280,000	Common Stock
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 153.96 per share.	23 Jan 2025	15,826	1,257,800	-	154.0	2,436,571	Class A Common Stock
Cass Information Systems Inc	Eric H. Brunngraber	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,304	174,471 (1%)	0%		0	Common Stock
Westamerica Bancorp	Curtis Belton	SVP/Risk Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,300	15,300	-		-	Non-qualified Stock Option (Right to Buy)
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.76 per share.	23 Jan 2025	15,166	46,468 (0%)	0%	17.8	269,348	Common Shares
Xenon Pharma Inc	Ian C. Mortimer	Director, PRESIDENT & CEO	Sale of securities on an exchange or to another person at price $ 40.46 per share.	23 Jan 2025	15,166	31,302 (0%)	0%	40.5	613,616	Common Shares
Cardlytics Inc	Amit Gupta	Director, Chief Executive Officer	Sale of securities on an exchange or to another person at price $ 3.92 per share.	23 Jan 2025	15,160	215,494 (0%)	0%	3.9	59,427	Common Stock
Lightbridge Corp	Andrey Mushakov	EVP, Nuclear Operations	Sale of securities on an exchange or to another person at price $ 7.54 per share.	23 Jan 2025	15,000	209,893 (6%)	0%	7.5	113,093	Common Stock
Globus Medical Inc (Class A)	James R. Tobin	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	John A. DeFord	Director		23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	Robert Andrew Douglas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	Stephen T. Zarrilli	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	Ann D. Rhoads	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	Lemaitre Dan	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	Leslie V. Norwalk	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	David D. Davidar	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Globus Medical Inc (Class A)	Daniel J. Wolterman	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	15,000	15,000	-		-	Stock Option (Right to Buy Class A Common Stock)
Westamerica Bancorp	Robert Baker	SVP/Banking Division Manager	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	14,700	14,700	-		-	Non-qualified Stock Option (Right to Buy)
Westamerica Bancorp	Robert Baker	SVP/Banking Division Manager	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	14,700	14,700	-		-	Non-qualified Stock Option (Right to Buy)
Westamerica Bancorp	George S. Ensinger	SVP/Human Resources Div. Mgr	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	14,400	14,400	-		-	Non-qualified Stock Option (Right to Buy)
Ramaco Resources Inc (Class A)	Jason Todd Fannin	CHIEF COMMERCIAL OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share.	23 Jan 2025	14,265	142,344	-	9.7	138,513	Class A common stock
T Stamp Inc (Class A)	Andrew Gowasack	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	13,478	25,487	-		-	Restricted Stock Units
Walmart	John R. Furner	Executive Vice President	Sale of securities on an exchange or to another person at price $ 92.96 per share.	23 Jan 2025	13,125	568,626 (0%)	0%	93.0	1,220,100	Common
Phreesia Inc	Allison Hoffman	General Counsel & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	12,791	158,917 (0%)	0%		0	Common Stock
Wintrust Fin Corp	David A. Dykstra	VICE CHAIRMAN AND COO	Grant, award, or other acquisition of securities at price $ 133.62 per share.	23 Jan 2025	12,780	210,507 (0%)	0%	133.6	1,707,664	Common Stock
A10 Networks Inc	Brian Becker	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,702	0	-		-	Performance-based Restricted Stock Units
A10 Networks Inc	Brian Becker	Chief Financial Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,702	54,828 (0%)	0%		0	Common Stock
J.B. Hunt Transport	John N. Roberts	Director, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	12,616	12,616	-		-	Restricted Stock
Mirum Pharma Inc	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,500	25,000	-		-	Restricted Stock Units
Mirum Pharma Inc	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,500	131,859 (0%)	0%		-	Common Stock
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 147.87 per share.	23 Jan 2025	12,375	1,044,179	-	147.9	1,829,891	Class A Common Stock
Ramaco Resources Inc (Class A)	Jeremy R. Sussman	CHIEF FINANCIAL OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share.	23 Jan 2025	12,131	333,184	-	9.7	117,792	Class A common stock
Ramaco Resources Inc (Class A)	John C. Marcum	EVP for Production	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,094	129,451	-		0	Class A common stock
Ramaco Resources Inc (Class A)	John C. Marcum	EVP for Production	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,094	0	-		-	Performance Stock Units
Progress Software Corp	YuFan Stephanie Wang	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	12,011	12,011	-		-	Restricted Stock Units
TKO (Class A)	Ariel Z. Emanuel	Director, Chief Executive Officer, Ten Percent Owner	Purchase of securities on an exchange or from another person at price $ 148.86 per share.	23 Jan 2025	12,005	1,056,184	-	148.9	1,787,064	Class A Common Stock
Lithium Americas Corp	Alexi Zawadzki	VP, Resource Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,002	24,004	-		-	Restricted Stock Units
Lithium Americas Corp	Alexi Zawadzki	VP, Resource Development	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	12,002	371,686	-		0	Common Shares
Franklin Covey Co.	Robert A. Whitman	Director	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	11,975	698,153 (5%)	0%		0	common shares
CarGurus Inc (Class A)	Langley Steinert	Director, Executive Chair, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 38.76 per share.	23 Jan 2025	11,886	695,356 (0%)	0%	38.8	460,653	Class A Common Stock
Symbotic Inc (Class A)	William M. Boyd	Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	11,634	23,274	-		-	Restricted Stock Units
Symbotic Inc (Class A)	William M. Boyd	Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	11,634	43,472	-		-	Class A Common Stock
X4 Pharma Inc	Christophe Arbet-Engels	Chief Medical Officer		23 Jan 2025	11,624	14,207 (0%)	0%	0.5	5,284	Common Stock
Arcus Biosciences Inc	Alexander Azoy	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	11,400	11,400	-		-	Stock Option (right to buy)
Alnylam Pharma Inc	Phillip A. Sharp	Director		23 Jan 2025	11,250	11,250 (0%)	0%	131.2	1,476,113	Common Stock
Alnylam Pharma Inc	Phillip A. Sharp	Director		23 Jan 2025	11,250	0 (0%)	0%	275	3,093,750	Common Stock
Alnylam Pharma Inc	Phillip A. Sharp	Director		23 Jan 2025	11,250	0	-		-	Stock Option (right to buy)
Minerals Tech Inc Results Board Meeting	Douglas T. Dietrich	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	11,017	83,926	-		-	Deferred Restricted Stock Units (DRSUs)
Minerals Tech Inc Results Board Meeting	Douglas T. Dietrich	Director, Chairman and CEO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	11,017	156,564 (0%)	0%		0	Common Stock
J.B. Hunt Transport	Nicholas Hobbs	EVP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	10,774	10,774	-		-	Restricted Stock
Progress Software Corp	John Ainsworth	EVP/GM App & Data Platform	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	10,255	10,255	-		-	Restricted Stock Units
Progress Software Corp	Loren Jarrett	EVP/GM Digital Experience	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	10,255	10,255	-		-	Restricted Stock Units
Progress Software Corp	Sundar Subramanian	EVP/GM Infrastructure Mgmt	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	10,255	10,255	-		-	Restricted Stock Units
Lightbridge Corp	Andrey Mushakov	EVP, Nuclear Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.82 per share.	23 Jan 2025	10,070	219,963 (6%)	0%	3.8	38,467	Common Stock
Lightbridge Corp	Andrey Mushakov	EVP, Nuclear Operations	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	10,070	59,891	-		-	Employee Stock Option (right to buy)
Progress Software Corp	Ian Pitt	Chief Information Officer		23 Jan 2025	10,057	10,057	-		-	Employee Stock Options (Right to buy)
T Stamp Inc (Class A)	Andrew Scott Francis	Director, Chief Technology Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	10,025	18,958	-		-	Restricted Stock Units
Equillium Inc	Jason A. Keyes	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 0.65 per share.	23 Jan 2025	10,000	37,720 (0%)	0%	0.7	6,500	Common Stock
Pricesmart Inc	Robert E. Price	Director, Ten Percent Owner	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	10,000	1,114,937 (3%)	0%		0	Common Stock
Blend Labs Inc (Class A)	Winnie Ling	HEAD OF LEGAL AND PEOPLE	Sale of securities on an exchange or to another person at price $ 3.73 per share.	23 Jan 2025	10,000	318,781	-	3.7	37,264	Class A Common Stock
Fastly Inc (Class A)	Artur Bergman	Director, Chief Technology Officer	Sale of securities on an exchange or to another person at price $ 10.12 per share.	23 Jan 2025	10,000	3,384,136 (4%)	0%	10.1	101,200	Class A Common Stock
i3 Verticals Inc (Class A)	David M. Wilds	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2025	9,979	260,657	-		0	Class B common stock, par value $0.0001 per share
i3 Verticals Inc (Class A)	David M. Wilds	Director	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2025	9,899	258,576	-		0	Class B common stock, par value $0.0001 per share
J.B. Hunt Transport	Darren P. Field	EVP and President Intermodal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	9,893	9,893	-		-	Restricted Stock
i3 Verticals Inc (Class A)	Clay Whitson	Director, Chief Strategy Officer	Sale or transfer of securities back to the company at price $ 0.00 per share.	23 Jan 2025	9,708	253,584	-		0	Class B common stock, par value $0.0001 per share
Wintrust Fin Corp	Richard B. Murphy	VICE CHAIR,CHIEF LENDING OFC	Grant, award, or other acquisition of securities at price $ 133.62 per share.	23 Jan 2025	9,689	52,000 (0%)	0%	133.6	1,294,644	Common Stock
Haverty Furniture Cos. Inc	Steven G. Burdette	President and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	9,348	9,348	-		-	RSUs 2025
DMC Global Inc	Eric V. Walter	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.19 per share.	23 Jan 2025	8,988	77,894 (0%)	0%	7.2	64,624	Common Stock
Burke & Herbert Fin Services Corp Results	Roy E. Halyama	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	8,976	15,123	-		0	Common Stock
Symbotic Inc (Class A)	William M. Boyd	Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,826	31,838	-		-	Class A Common Stock
Symbotic Inc (Class A)	William M. Boyd	Chief Strategy Officer	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,826	35,304	-		-	Restricted Stock Units
J.B. Hunt Transport	Bradley W. Hicks	President of DCS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	8,777	8,777	-		-	Restricted Stock
Enphase Energy Results Board Meeting	Mandy Yang	EVP, Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	8,580	88,998 (0%)	0%		0	Common Stock
Burke & Herbert Fin Services Corp Results	H. Charles Maddy	Director, President	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	8,580	32,705	-		0	Common Stock
Charles Schwab Analyst Downgrade Board Meeting	Arun Sarin	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 31.21 per share.	23 Jan 2025	8,548	9,204 (0%)	0%	31.2	266,783	Common Stock
Charles Schwab Analyst Downgrade Board Meeting	Arun Sarin	Director	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,548	0	-		-	Nonqualified Stock Option (right to buy)
Charles Schwab Analyst Downgrade Board Meeting	Arun Sarin	Director	Sale of securities on an exchange or to another person at price $ 81.82 per share.	23 Jan 2025	8,548	18,617 (0%)	0%	81.8	699,406	Common Stock
Lithium Americas Corp	Edward Grandy	Sr VP, GC & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,374	101,349	-		-	Common Shares
Lithium Americas Corp	Edward Grandy	Sr VP, GC & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,374	16,749	-		-	Restricted Share Units
D-Wave Quantum Inc	Alan Baratz	Director, President & CEO	Sale of securities on an exchange or to another person at price $ 5.27 per share.	23 Jan 2025	8,372	2,342,208	-	5.3	44,120	Common Stock, par value $0.0001 per share ("Common Stock")
D-Wave Quantum Inc	Alan Baratz	Director, President & CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.27 per share.	23 Jan 2025	8,372	2,342,208	-	5.3	44,120	Common Stock, par value $0.0001 per share ("Common Stock")
Cass Information Systems Inc	Martin H. Resch	President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	8,303	38,322 (0%)	0%		0	Common Stock
J.B. Hunt Transport	John Kuhlow	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	8,239	8,239	-		-	Resticted Stock
Ramaco Resources Inc (Class A)	Christopher L. Blanchard	EVP Mine Planning & Developmen	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,086	90,924	-		0	Class B common stock
Ramaco Resources Inc (Class A)	Christopher L. Blanchard	EVP Mine Planning & Developmen	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,086	0	-		-	Performance Stock Units
Ramaco Resources Inc (Class A)	Jeremy R. Sussman	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,086	75,300	-		0	Class B common stock
Ramaco Resources Inc (Class A)	Jeremy R. Sussman	CHIEF FINANCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	8,086	0	-		-	Performance Stock Units
Pricesmart Inc	John D. Hildebrandt	President and COO	Sale of securities on an exchange or to another person at price $ 90.51 per share.	23 Jan 2025	8,020	123,547 (0%)	0%	90.5	725,906	Common Stock, $0.0001 par value per share
Phreesia Inc	Amy Beth VanDuyn	SVP, Human Resources	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	7,900	118,209 (0%)	0%		0	Common Stock
Phreesia Inc	Balaji Gandhi	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	7,900	149,746 (0%)	0%		0	Common Stock
Lithium Americas Corp	Edward Grandy	Sr VP, GC & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	7,819	109,168	-		-	Common Shares
Lithium Americas Corp	Edward Grandy	Sr VP, GC & Secretary	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	7,819	0	-		-	Restricted Share Units
DoorDash	Prabir Adarkar	PRESIDENT AND COO	Sale of securities on an exchange or to another person at price $ 182.92 per share.	23 Jan 2025	7,728	926,022	-	182.9	1,413,637	Class A Common Stock
Pinnacle Financial Partners	M Terry Turner	Director, CEO	Grant, award, or other acquisition of securities at price $ 122.34 per share.	23 Jan 2025	7,725	225,856 (0%)	0%	122.3	945,077	PNFP Common Stock
J.B. Hunt Transport	Stuart Scott	EVP/CIO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	7,399	7,399	-		-	Restricted Stock
Progress Software Corp	Ian Pitt	Chief Information Officer		23 Jan 2025	7,391	7,391	-		-	Restricted Stock Units
Wintrust Fin Corp	David L. Stoehr	CHIEF FINANCIAL OFFICER	Grant, award, or other acquisition of securities at price $ 133.62 per share.	23 Jan 2025	7,347	22,221 (0%)	0%	133.6	981,706	Common Stock
Pinnacle Financial Partners	Robert A. Mccabe	Director, CHAIRMAN	Grant, award, or other acquisition of securities at price $ 122.34 per share.	23 Jan 2025	7,340	155,969 (0%)	0%	122.3	897,976	PNFP Common Stock
Franklin Covey Co.	Robert A. Whitman	Director	Gift of securities by or to the insider at price $ 0.00 per share.	23 Jan 2025	7,302	710,128 (5%)	0%		0	common shares
A10 Networks Inc	Robert Scott Weber	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	7,290	40,963 (0%)	0%		0	Common Stock
A10 Networks Inc	Robert Scott Weber	General Counsel	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	7,290	0	-		-	Performance-based Restricted Stock Units
Cass Information Systems Inc	Martin H. Resch	President & CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	7,211	43,302 (0%)	0%		0	Common Stock
Astrana Health Inc	Dinesh Kumar	Chief Medical Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.96 per share.	23 Jan 2025	7,210	209,291 (0%)	0%	38.0	273,692	Common Stock
Progress Software Corp	YuFan Stephanie Wang	Chief Legal Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	7,207	7,207	-		-	Restricted Stock Units
J.B. Hunt Transport	Nicholas Hobbs	EVP and COO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	7,182	7,182	-		-	Restricted Stock
Wintrust Fin Corp	Thomas P. Zidar	EXECUTIVE VICE PRESIDENT	Grant, award, or other acquisition of securities at price $ 133.62 per share.	23 Jan 2025	7,096	51,950 (0%)	0%	133.6	948,168	Common Stock
Cass Information Systems Inc	Eric H. Brunngraber	Director, Executive Chairman	Payment of exercise price or tax liability using portion of securities received from the company at price $ 41.10 per share.	23 Jan 2025	7,046	167,425 (1%)	0%	41.1	289,591	Common Stock
Lithium Americas Corp	Aubree Barnum	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	7,037	14,074	-		-	Restricted Share Units
Lithium Americas Corp	Aubree Barnum	VP, Human Resources	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	7,037	38,276	-		0	Common Shares
Ramaco Resources Inc (Class A)	Randall W. Atkins	Director, CHIEF EXECUTIVE OFFICER	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.15 per share.	23 Jan 2025	6,912	107,567	-	9.2	63,245	Class B common stock
Ramaco Resources Inc (Class A)	Jason Todd Fannin	CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,911	33,723	-		0	Class B common stock
Ramaco Resources Inc (Class A)	Jason Todd Fannin	CHIEF COMMERCIAL OFFICER	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,911	0	-		-	Performance Stock Units
Mirum Pharma Inc	Christopher Peetz	Director, CHIEF EXECUTIVE OFFICER	Sale of securities on an exchange or to another person at price $ 47.92 per share.	23 Jan 2025	6,837	125,022 (0%)	0%	47.9	327,658	Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	6,666	211,006	-		-	Class B Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Sale of securities on an exchange or to another person at price $ 88.50 per share.	23 Jan 2025	6,666	0 (0%)	0%	88.5	589,941	Class A Common Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director		23 Jan 2025	6,666	6,666 (0%)	0%		0	Class A Common Stock
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,629	13,257	-		-	Restricted Share Units
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,629	91,617	-		0	Common Shares
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,629	91,617	-		0	Common Shares
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,629	13,257	-		-	Restricted Share Units
J.B. Hunt Transport	Darren P. Field	EVP and President Intermodal	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	6,595	6,595	-		-	Restricted Stock
Okta Inc (Class A)	Jacques Frederic Kerrest	Director	Sale of securities on an exchange or to another person at price $ 87.57 per share.	23 Jan 2025	6,513	100 (0%)	0%	87.6	570,325	Class A Common Stock
Wintrust Fin Corp	Kathleen M. Boege	EVP, GENERAL COUNSEL AND SEC	Grant, award, or other acquisition of securities at price $ 133.62 per share.	23 Jan 2025	6,293	26,169 (0%)	0%	133.6	840,871	Common Stock
Minerals Tech Inc Results Board Meeting	Douglas T. Dietrich	Director, Chairman and CEO	Payment of exercise price or tax liability using portion of securities received from the company at price $ 75.65 per share.	23 Jan 2025	6,129	150,435 (0%)	0%	75.7	463,659	Common Stock
Washington Trust Bancorp Inc Results Board Meeting High Gain High Volume	Edward O. Handy	Director, Chairman and CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	6,066	25,986 (0%)	0%		0	Common Stock
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,032	0	-		-	Restricted Share Units
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,032	97,649	-		0	Common Shares
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,032	0	-		-	Restricted Share Units
Lithium Americas Corp	Timothy Ambrose Crowley	VP, Gov & External Affairs	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	6,032	97,649	-		0	Common Shares
Spar Grp Inc	Robert G. Brown	Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 1.98 per share.	23 Jan 2025	5,997	2,447,996 (11%)	0%	2.0	11,874	Common Stock, $.01 par value
Ramaco Resources Inc (Class A)	John C. Marcum	EVP for Production	Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.71 per share.	23 Jan 2025	5,883	123,568	-	9.7	57,124	Class A common stock
Netflix Estimates Miss	Spencer Adam Neumann	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,870	5,870	-		-	Restricted Stock Units
J.B. Hunt Transport	Bradley W. Hicks	President of DCS	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,851	5,851	-		-	Restricted Stock
Manhattan Associates Inc Results Board Meeting	Robert G. Howell	EVP, Americas Sales	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,825	157,767 (0%)	0%		0	Common Stock
Manhattan Associates Inc Results Board Meeting	James Stewart Gantt	EVP, Professional Services	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,825	48,637 (0%)	0%		0	Common Stock
Mirum Pharma Inc	Peter Radovich	PRESIDENT AND COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	5,750	32,765 (0%)	0%		-	Common Stock
Mirum Pharma Inc	Peter Radovich	PRESIDENT AND COO	Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share.	23 Jan 2025	5,750	11,500	-		-	Restricted Stock Units
Haverty Furniture Cos. Inc	Richard B. Hare	Executive Vice President & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,693	5,693	-		-	RSUs 2025
Manhattan Associates Inc Results Board Meeting	Dennis B. Story	EVP, CFO & Treasurer		23 Jan 2025	5,673	105,424 (0%)	0%		0	Common Stock
Microvast Holdings Inc	Wenjuan Mattis	Chief Technology Officer (CTO)	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,651	808,189	-		-	Common Stock
D-Wave Quantum Inc	John M. Markovich	Chief Financial Officer	Sale of securities on an exchange or to another person at price $ 5.27 per share.	23 Jan 2025	5,582	1,064,556	-	5.3	29,417	Common Stock, par value $0.0001 per share ("Common Stock")
D-Wave Quantum Inc	John M. Markovich	Chief Financial Officer	Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.27 per share.	23 Jan 2025	5,582	1,064,556	-	5.3	29,417	Common Stock, par value $0.0001 per share ("Common Stock")
Progress Software Corp	Domenic LoCoco	Chief Accounting Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,544	5,544	-		-	Restricted Stock Units
J.B. Hunt Transport	John Kuhlow	EVP & CFO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,493	5,493	-		-	Resticted Stock
Cass Information Systems Inc	Eric H. Brunngraber	Director, Executive Chairman	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,422	163,591 (1%)	0%		0	Common Stock
Data io Corp Results Board Meeting	Garrett Riley Larson	Director	Grant, award, or other acquisition of securities at price $ 2.91 per share.	23 Jan 2025	5,272	5,272 (0%)	0%	2.9	15,342	Common Stock
RPC Inc Results Board Meeting	Michael L. Schmit	CFO and Corporate Secretary	Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.86 per share.	23 Jan 2025	5,256	101,275 (0%)	0%	6.9	36,056	Common Stock, $.10 Par Value
Aramark	Karen M. King	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,000	37,523 (0%)	0%		0	Common Stock
Arcus Biosciences Inc	David L. Lacey	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,000	5,000	-		-	Stock Option (right to buy)
Arcus Biosciences Inc	Antoni Ribas	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	23 Jan 2025	5,000	5,000	-		-	Stock Option (right to buy)
Citizens Community Bancorp Inc MD	Stephen Bianchi	Director, CEO and President	Grant, award, or other acquisition of securities at price $ 16.09 per share.	23 Jan 2025	4,985	75,394 (0%)	0%	16.1	80,209	Common Stock, par value $0.01 per share

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.

Insider trading for US stocks based on disclosures made made on Jan 23, 2025

Monitor US insider transactions and discover insider buying and selling of stocks on Jan 23, 2025.

The latest disclosure under SEC insider trading regulations was reported by Roivant Sciences Ltd., where the revocation of 13,357,857 Common Shares of common stock was executed . This transaction was reported to the Securities and Exchange Commission on Jan. 23, 2025.

Screeners based on Insider Trading parameters